Inferensys

Guide

How to Implement a Model Explainability Layer for Regulatory Compliance

A technical guide to building an explainability layer for clinical prediction models using SHAP and LIME. Includes code for generating patient-level explanations, audit reports, and visualizations to meet regulatory requirements like the EU AI Act.
Compliance team using AI for regulatory reporting on laptop, SEC templates visible, modern office desk setup.

This guide details how to integrate explainable AI (XAI) techniques like SHAP and LIME into clinical prediction models to meet regulatory requirements such as the EU AI Act.

In precision medicine, AI models that stratify patients or predict treatment response are classified as high-risk AI systems under regulations like the EU AI Act. This mandates transparency and explainability—you must provide clear, auditable reasoning for each prediction. An explainability layer is a technical component that generates patient-level feature attributions (e.g., which genomic variant drove a high-risk score) and aggregate reports for model audits. Techniques like SHAP (SHapley Additive exPlanations) and LIME (Local Interpretable Model-agnostic Explanations) are foundational for this task.

Implementation requires integrating XAI libraries directly into your MLOps pipeline. For a production model, you generate explanations during inference, storing them alongside predictions in a secure log. You then visualize these for clinicians via dashboards, highlighting key biomarkers. Crucially, you must balance model performance with interpretability demands; sometimes a slightly less complex model is preferable if its logic is more defensible. This layer is essential for building trust and meeting the transparency requirements outlined in our guide on How to Establish a Data Governance Framework for Clinical AI Models.

EXPLAINABILITY METHOD SELECTION

SHAP vs. LIME: Method Comparison for Clinical Use

A direct comparison of two leading local explainability methods for generating patient-level explanations in regulated clinical AI models.

Feature / MetricSHAP (SHapley Additive exPlanations)LIME (Local Interpretable Model-agnostic Explanations)

Theoretical Foundation

Game theory (Shapley values)

Local surrogate modeling

Explanation Consistency

Local Fidelity Guarantee

Global guarantee

Local approximation only

Computational Cost

High (kernel, TreeSHAP varies)

Low to Moderate

Handles Feature Dependence

KernelSHAP: No, TreeSHAP: Yes

No (assumes independence)

Output for Classification

Probability contribution per class

Feature weights for a single class

Integration with EU AI Act

High (provides robust, consistent trace)

Moderate (requires validation of local fidelity)

Common Clinical Implementation

shap.Explainer() with model output

lime.lime_tabular.LimeTabularExplainer()

EXPLAINABLE AI (XAI)

Common Mistakes

Implementing an explainability layer is critical for regulatory compliance in healthcare, but developers often stumble on technical and procedural pitfalls. This section addresses the most frequent errors that compromise audit readiness and clinical trust.

SHAP calculations often fail in production due to data distribution shifts between your training set and real-world inference data. The SHAP explainer, typically fitted on a background dataset, becomes unreliable when feature values fall outside its expected range.

Common Fixes:

  • Dynamic Background Sampling: Periodically update the explainer's background data with a representative sample from recent production inferences.
  • Data Drift Monitoring: Implement statistical tests (Population Stability Index, Kolmogorov-Smirnov) to trigger explainer retraining.
  • Fallback Mechanisms: Use a simpler, more robust method like LIME as a backup when SHAP fails, logging the incident for audit.

Always validate your explanation outputs as part of your model monitoring pipeline, not just the predictions.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.